Published in Cytokine on March 14, 2009
Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis. Aliment Pharmacol Ther (2015) 2.00
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? World J Gastroenterol (2010) 0.91
C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study. BMC Gastroenterol (2015) 0.87
Predictors of response to anti-tumor necrosis factor therapy in ulcerative colitis. World J Gastrointest Pathophysiol (2014) 0.86
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis. Aliment Pharmacol Ther (2014) 0.79
Elevation of PRKCDBP, a novel transcriptional target of TNF-α, and its downregulation by infliximab in patients with ulcerative colitis. Dig Dis Sci (2014) 0.78
Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis. Int J Colorectal Dis (2013) 0.76
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease. Medicine (Baltimore) (2016) 0.76
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. Eur J Clin Pharmacol (2015) 0.75
Can We Predict the Efficacy of Anti-TNF-α Agents? Int J Mol Sci (2017) 0.75
Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell (2008) 4.43
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. Hepatology (2008) 2.59
Evaluation of absolute quantitation by nonlinear regression in probe-based real-time PCR. BMC Bioinformatics (2006) 2.23
The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway. Scand J Gastroenterol (2009) 1.41
Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology (2005) 1.26
IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res (2011) 1.26
Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter (2007) 1.14
TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine (2011) 1.10
Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population. PLoS One (2011) 1.09
Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursors. Cancer Res (2005) 1.08
Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol (2007) 1.05
Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics (2010) 1.04
Gastrin-induced apoptosis contributes to carcinogenesis in the stomach. Lab Invest (2006) 1.01
Transcriptional regulation of the human trefoil factor, TFF1, by gastrin. Gastroenterology (2003) 1.00
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis (2011) 0.99
Body mass index and mortality in elderly men and women: the Tromso and HUNT studies. J Epidemiol Community Health (2011) 0.99
Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol (2007) 0.97
The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol (2009) 0.96
Risk of malnutrition and health-related quality of life in community-living elderly men and women: the Tromsø study. Qual Life Res (2010) 0.95
Body mass index and disease burden in elderly men and women: the Tromsø Study. Eur J Epidemiol (2010) 0.95
Prevalence of common mutations in the CYP17A1 gene in Chinese Han population. Clin Chim Acta (2011) 0.91
Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Scand J Gastroenterol (2012) 0.90
Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother (2006) 0.89
Experiences with three different fiber supplements in weight reduction. Med Sci Monit (2005) 0.89
Glycine-extended gastrin promotes the growth of lung cancer. Cancer Res (2004) 0.89
Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis. Scand J Gastroenterol (2009) 0.89
Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease. Pharmacogenet Genomics (2011) 0.88
No evidence for association of 12p13 SNPs rs11833579 and rs12425791 within NINJ2 gene with ischemic stroke in Chinese Han population. Atherosclerosis (2011) 0.87
Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets? Scand J Gastroenterol (2012) 0.86
Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence. APMIS (2008) 0.85
IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence. Scand J Gastroenterol (2012) 0.85
Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test. Scand J Gastroenterol (2013) 0.85
Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer. Cancer Immunol Immunother (2014) 0.85
Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol (2008) 0.85
Polarization of cytokine profile from Th1 into Th2 along colorectal adenoma-carcinoma sequence: implications for the biotherapeutic target? Inflamm Allergy Drug Targets (2008) 0.85
Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke. Stroke (2009) 0.84
Progressive cellular response in the lamina propria of the colorectal adenoma-carcinoma sequence. Histopathology (2009) 0.84
Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas. Tumour Biol (2011) 0.84
Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother (2007) 0.84
New specific molecular targets for radio-chemotherapy of rectal cancer. Mol Oncol (2009) 0.83
Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scand J Gastroenterol (2012) 0.83
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One (2013) 0.83
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations? Med Oncol (2011) 0.83
Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome. Appetite (2012) 0.82
Distinct compartmental distribution of mature and immature dendritic cells in esophageal squamous cell carcinoma. Pathol Res Pract (2010) 0.82
Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease. Scand J Gastroenterol (2013) 0.81
Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas. Pathol Oncol Res (2007) 0.81
Genetic polymorphism of CYP11B2 gene and stroke in the Han Chinese population and a meta-analysis. Pharmacogenet Genomics (2011) 0.81
Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas. Virchows Arch (2009) 0.80
Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas. APMIS (2008) 0.80
Risk of malnutrition is associated with mental health symptoms in community living elderly men and women: the Tromsø study. BMC Psychiatry (2011) 0.80
Prevalences of viremic hepatitis C and viremic hepatitis B in pregnant women in Northern Norway. Hepatogastroenterology (2009) 0.79
Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother (2009) 0.79
Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional. Patient Prefer Adherence (2012) 0.79
Immunohistochemical examination of gastrin, gastrin precursors, and gastrin/CCK-2 receptor in human esophageal squamous cell carcinomas. Pathol Oncol Res (2008) 0.79
The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scand J Gastroenterol (2012) 0.78
A sensitive method for the analysis of glutathione in porcine hepatocytes. Scand J Gastroenterol (2014) 0.77
Common variants in KCNQ1 confer increased risk of type 2 diabetes and contribute to the diabetic epidemic in East Asians: a replication and meta-analysis. Ann Hum Genet (2013) 0.77
Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (2013) 0.77
Association analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population. PLoS One (2013) 0.77
[Hepatitis C in Northern Norway--an 8-year material]. Tidsskr Nor Laegeforen (2002) 0.76
Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway. Scand J Gastroenterol (2010) 0.76
The role of interleukin-17A in colorectal tumorigenesis. Cancer Biother Radiopharm (2013) 0.76
Comparison of high-resolution melting analysis, TaqMan Allelic discrimination assay, and sanger sequencing for Clopidogrel efficacy genotyping in routine molecular diagnostics. J Mol Diagn (2013) 0.76
Association between variants of EXT2 and type 2 diabetes: a replication and meta-analysis. Hum Genet (2012) 0.76
Acetabular dysplasia as an aetiological factor in development of hip osteoarthritis. Int Orthop (2008) 0.76
The economic burden of TNFα inhibitors and other biologic treatments in Norway. Clinicoecon Outcomes Res (2011) 0.75
Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence. Pathol Oncol Res (2014) 0.75
Cytokine mRNA expression in steroid-naïve patients with ulcerative colitis. Inflamm Bowel Dis (2010) 0.75
Research misconduct: Dr Grethe Stoa Birketvedt not guilty of scientific misconduct. J R Soc Med (2010) 0.75
Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm. Eur J Gastroenterol Hepatol (2017) 0.75
The expression of non-mast histamine in tumor associated microvessels in human colorectal cancers. Pathol Oncol Res (2012) 0.75